Skip to main content

Month: May 2021

Equinor ASA: Equinor’s share saving plan allocates shares

The shares purchased by DNB on behalf of Equinor (OSE: EQNR, NYSE: EQNR) on 14 May 2021 for use in the group’s share saving plan have on 20 May 2021 been distributed to the employees in accordance with their savings amount. Following this, the share saving plan has 10,393,765 shares. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act

Continue reading

B Share Extension of Offer

Seneca Growth Capital VCT Plc 20 May 2021 Extension of Offer         On 13 October 2020 Seneca Growth Capital VCT Plc (the “Company”) launched an offer for subscription for B shares to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the “Offer”). Full details of the Offer are contained in a prospectus issued by the Company on that date (the “Prospectus”). Pursuant to the terms and conditions of the Offer set out in the Prospectus, the Offer may be extended by the Directors at their absolute discretion to a date no later than 24 September 2021. Accordingly, the Directors of the Company have agreed to extend the closing date of the Offer from 5.00 p.m. 28 May 2021 to 5.00 p.m. 24 September 2021, unless previously fully subscribed...

Continue reading

Maersk Drilling releases Q1 2021 Trading Statement: Strong commercial performance improves expectations for 2021

Today, the Board of Directors of The Drilling Company of 1972 A/S (“Maersk Drilling”) has adopted the trading statement for the first quarter of 2021 (Q1 2021): Performance highlights for Q1 2021 (Q4 2020 in brackets)Revenue of USD 264m (USD 286m) Contracted days were 1,199 (1,204) resulting in a utilisation of 61% (59%) Average day rate excluding one-offs of USD 217k (USD 221k) Financial uptime of 92.9% (98.9%) Secured contracts with a total contract value of USD 730m (USD 65m) Revenue backlog of USD 1.8bn at 31 March 2021 (USD 1.3bn at 31 December 2020). Forward contract coverage for the remainder of 2021 of 64% and 24% for 2022.Guidance for 2021The full-year guidance for 2021 was revised on 19 May 2021 as follows:•    Profit before depreciation and amortisation, impairment losses/reversals and special items (EBITDA before special...

Continue reading

Announcement of “VALMIERAS STIKLA ŠĶIEDRA” about the results of mandatory buyout offer

By the decision of the Financial and Capital Market Commission of April 13, 2021, Duke I S.à r.l. (a private limited company entered on the Trade and Companies Register of the Grand Duchy of Luxembourg, registration number B247170, registered office at 11-13 Boulevard de la Foire, L-1528 Luxembourg, Grand Duchy of Luxembourg) was authorized to make a mandatory buyout offer to the shareholders of the joint-stock company „VALMIERAS STIKLA ŠĶIEDRA” (registration number: 40003031676, registered address: Cempu iela 13, Valmiera, LV-4201, Latvija) pursuant to the article 66 section 4 subsections 1) and 2) of the Financial Instruments Market Law. The mandatory buyout offer closed on May 17, 2021 (16:00 GMT + 2). THE RESULTS OF BUYOUT OFFER: Number of shares offered for saleWithin the framework of the mandatory share buyout offer, it was offered...

Continue reading

Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning

Tecentriq improved disease-free survival by more than one-third in people with PD-L1-positive resectable early-stage lung cancer, compared with best supportive care First and only cancer immunotherapy to show positive Phase III results in the adjuvant lung cancer setting New adjuvant treatment options are urgently needed in early lung cancer to help the approximately 50% of people who currently experience recurrence following surgeryBasel, 20 May 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq® (atezolizumab) following surgery and chemotherapy reduced the risk of disease recurrence or death (disease-free survival; DFS) by 34% (hazard ratio [HR]=0.66, 95% CI: 0.50–0.88) in people with Stage II-IIIA non-small cell lung...

Continue reading

Parrot: 2021 FIRST-QUARTER BUSINESS

  PRESS RELEASEParis, May 20, 2021, 7am CET2021 FIRST-QUARTER BUSINESS For the first quarter of 2021, the Parrot Group is reporting consolidated revenues of €12.4m. The American subsidiary specialized in precision farming sensors (Micasense), sold on January 27, 2021, is no longer consolidated from the first quarter of 2021 and its revenues have been eliminated from 2020 to obtain a comparable basis. The realignment around commercial drones is delivering a range of benefits: at constant exchange rates, Group revenues (comparable basis) are up 6.5% (stable at current exchange rates) compared with the first quarter of 2020. Over the period, the Group’s commercial development was marked by:The 50.5% increase in revenues for micro-drones (+56.9% at current exchange rates) to €4.8m, driven by strong sales growth for commercial micro-drones...

Continue reading

Anaqua Acquires Actio IP to Offer Integrated Tech-Enabled Foreign Filing Solutions

Acquisition expands Anaqua’s offerings with easy-to-use platform, supported by exceptional customer service, to help IP practitioners streamline their global filings process BOSTON, May 20, 2021 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that it has acquired tech-enabled IP services company Actio IP from Acapo AS. The transaction further strengthens Anaqua’s strategic line of IP management solutions, offering corporations and law firms an intuitive, transparent, and efficient experience in managing the Patent Cooperation Treaty (PCT) National Phase and European Patent (EP) Validation filing processes. Anaqua will continue to enhance Actio IP’s tech-enabled foreign filing services platform, ACTIO Portal, while significantly investing in the integration...

Continue reading

Results of the takeover offer with respect to AS Tallinna Vesi’s shares

On 13 April 2021, the majority shareholders of AS Tallinna Vesi – City of Tallinn and OÜ Utilitas hereinafter jointly referred to as the Offerors) – notified of the mandatory takeover offer for the acquisition of all A-shares in AS Tallinna Vesi, which are not owned by the Offerors, for a purchase price of 14.20 euros (fourteen euros and twenty eurocents) per share („Purchase Price“) on the terms and conditions set out in the takeover offer. The time allowed for the acceptance of an offer ended on 17/05/2021 at 15:00, Estonian time (Eastern European Summer Time). As response to the Offer, the shareholders of ASTV who accepted the Offer decided to sell 1,083,834 A-shares of ASTV, which equals to approximately 5.42% of all A-shares of ASTV. The payment of purchase price shall be in cash and the shares shall be transferred to the Offerors...

Continue reading

EVS Broadcast Equipment Q1 2021 Business update

Publication on May 20 2021, before market opening Regulated information.EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS Q1 2021 Business update – Strong post-Covid recovery in our 3 Market PillarsEVS global leader in live video technology for broadcast and new media productions today announces its business update for the first quarter ending 31 March 2021.HIGHLIGHTS2021 Booked revenues* as of March 31st are EUR 54,0 million (excl Big Event Rental), vs EUR 36,9 million at the same date last year (+ 46,3% vs last year). Considering the high probability that the large European and Asian summer sport events will take place, there is an additional EUR 13,2 million of revenues to be recognized for the Big Events Rental later this year. Operational expenses continue to be closely managed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.